Respiratory syncytial virus (RSV) disease – new data needed to guide future policy

Respiratory syncytial virus (RSV) disease – new data needed to guide future policy

RSV is the main cause of childhood lower respiratory infections, globally, an important cause of childhood wheeze and may be responsible for a substantial burden of disease in the very elderly and in adults with chronic medical problems, such as COPD. It is thus responsible for substantial healthcar...

Full description

Bibliographic Details
Main Authors:	Louis Bont, Harish Nair
Format:	Article
Language:	English
Published:	Edinburgh University Global Health Society 2015-12-01
Series:	Journal of Global Health
Subjects:	RSV new data
Online Access:	http://jogh.org/pdfviewer.aspx?pdf=documents/issue201502/jogh-05-020101.pdf

Similar Items

Towards Better Understanding of Respiratory Syncytial Virus (RSV) Vaccine-Induced Enhanced Disease
by: Muralidharan, Abenaya
Published: (2019)

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections
by: Wenzhe Wu, et al.
Published: (2020-03-01)

Does Respiratory Syncytial Virus (RSV) infection in the first two years of life contribute to the development of asthma among children in Manitoba?
by: Khan, Sazzadul Khan
Published: (2011)

Does Respiratory Syncytial Virus (RSV) infection in the first two years of life contribute to the development of asthma among children in Manitoba?
by: Khan, Sazzadul Khan
Published: (2011)

Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
by: Chiara Azzari, et al.
Published: (2021-10-01)

Data describing IFNγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (RSV)
by: Katherine M. Eichinger, et al.
Published: (2017-10-01)

Current Insights Into Host Immune Responses to Human Respiratory Syncytial Virus (RSV) and Challenges Towards Efficient Treatments and Vaccines Against RSV
Published: (2020)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
by: Samuel PC Brand, et al.
Published: (2020-03-01)

Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection
by: Sara A. Taleb, et al.
Published: (2021-08-01)

A Contemporary View of Respiratory Syncytial Virus (RSV) Biology and Strain-Specific Differences
by: Mansi C. Pandya, et al.
Published: (2019-05-01)

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
by: Lydia J. Atherton, et al.
Published: (2019-10-01)

A Classification Study of Respiratory Syncytial Virus (RSV) Inhibitors by Variable Selection with Random Forest
by: Shuwei Zhang, et al.
Published: (2011-02-01)

Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection
by: Winke Van der Gucht, et al.
Published: (2017-08-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
by: Mark R. Ackermann, et al.
Published: (2012-10-01)

Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection
by: In Su Cheon, et al.
Published: (2019-03-01)

Respiratory syncytial virus tracking using internet search engine data
by: Eyal Oren, et al.
Published: (2018-04-01)

Clinico demographic profiling of the Respiratory syncytial virus (RSV) infected children admitted in tertiary care hospital in North India
by: Charu Singh, et al.
Published: (2021-01-01)

The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors
by: Emanuele Andreano, et al.
Published: (2021-06-01)

Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV
by: Akihito Sawada, et al.
Published: (2021-02-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
by: Selir M. Straliotto, et al.
Published: (1994-03-01)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
by: Carlotta Biagi, et al.
Published: (2020-11-01)

Dominance of the ON1 Genotype of RSV-A and BA9 Genotype of RSV-B in Respiratory Cases from Jeddah, Saudi Arabia
by: Hessa A. Al-Sharif, et al.
Published: (2020-11-01)

Systematic Review of the Respiratory Syncytial Virus (RSV) Prevalence, Genotype Distribution, and Seasonality in Children from the Middle East and North Africa (MENA) Region
by: Hadi M. Yassine, et al.
Published: (2020-05-01)

Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade
by: Sofia S. Aranda, et al.
Published: (2019-05-01)

Burden of respiratory syncytial virus infections in China: Systematic review and meta–analysis
by: Yaowen Zhang, et al.
Published: (2015-12-01)

Comparison of methods for laboratory diagnosis of respiratory syncytial virus
by: Maria Cristina Arcangeletti, et al.
Published: (2010-09-01)

Role of Respiratory Syncytial Virus in Pediatric Pneumonia
by: Sonia Bianchini, et al.
Published: (2020-12-01)

Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus
by: Patricia A. Jorquera, et al.
Published: (2016-12-01)

RSV infection and recurrence of respiratory tract obstruction in children
by: Karolina Kapusta, et al.
Published: (2016-06-01)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
by: Maaike Nederend, et al.
Published: (2020-08-01)

Fulminant ecchymosis as the initial manifestation of antiphospholipid syndrome (APS) triggered by respiratory syncytial virus (RSV) infection: A case report and review of the literature
by: Jun Makino, et al.
Published: (2017-01-01)

Respiratory Syncytial Virus Persistence in Macrophages Upregulates Fcgamma Receptors Expression
by: Jorge Gaona, et al.
Published: (2014-02-01)

Effectiveness of Trino-IB on rat infected with respiratory syncytial virus
by: Oladipo Elijah Kolawole, et al.
Published: (2018-01-01)

Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
by: Shibo Jiang, et al.
Published: (2013-01-01)

Salvia plebeia R. Br. polysaccharides (SPP) against RSV (respiratory syncytial virus) infection: Antiviral effect and mechanisms of action
by: Yi-yu Liang, et al.
Published: (2021-09-01)

Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update
by: Yaneisi Vázquez, et al.
Published: (2019-06-01)

Neonatal Genetic Delivery of Anti-Respiratory Syncytial Virus (RSV) Antibody by Non-Human Primate-Based Adenoviral Vector to Provide Protection against RSV
by: Rika Gomi, et al.
Published: (2018-12-01)

Creola Bodies in Infancy with Respiratory Syncytial Virus Bronchiolitis Predict the Development of Asthma
by: Yumi Yamada, et al.
Published: (2010-01-01)

Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015–2017
by: Jenna E. Holmen, et al.
Published: (2021-03-01)

RSV Fusion: Time for a New Model
by: Richard G. Hegele, et al.
Published: (2013-03-01)